In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
Stop Googling. The answer is staring you right in the face—you just have to read it.
The road to Hershey gets bumpier on Wednesday as 3 of the 4 District 11 reps are going against district champs The Eagles could be set to lose multiple defensive starters in free agency. Who are the ...
Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...